Impact of Comorbidities on Racial/Ethnic Disparities in Hypertension in the United States
ISRN Public Health · 2013
DOI: 10.1155/2013/967518 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Public Health, 2013. Verfasst von Franklin Opara und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Background
Racial/ethnic disparities in hypertension (HTN) prevalence continue to persist in United States. We aimed in this study to examine the racial/ethnic disparities in hypertension prevalence and to determine whether or not health disparities may be explained by racial/ethnic disparities in co-morbidities. Materials and Methods . A cross-sectional design was used to examine the prevalence of hypertension among African Americans (AAs), Caucasians, and Hispanics in the National Health Interview Survey, 2003. The overall sample comprised 30, 852 adults.
Results
There was a statistically significant racial/ethnic variability in hypertension prevalence, with AA/Blacks with the highest prevalence, χ 2 = 393.0 (3), P < 0.01 . Hypertension was associated with co-morbidities, age, education, physical inactivity, marital status, income, sex, alcohol, and cigarette consumption, but not insurance. Relative to Caucasians, AAA/Blacks were 43% more likely while Hispanics were 40% less likely to report being diagnosed with high blood pressure, prevalence odds ratio (POR) = 1.43, 99% CI, 1.25–1.64, P = 0.002 , and POR = 0.60, 99% CI, 0.55–0.66, P < 0.001, respectively. After adjustment for the relevant covariates including co-morbidities, racial/ethnic disparities in hypertension persisted; thus compared to Caucasians, African Americans were 61% more likely to be told by their health care providers that they were hypertensive, adjusted prevalence odds ratio (APOR) = 1.61, 99% CI, 1.39–1.86, P < 0.001 . In contrast, Hispanics were 27% less likely to be diagnosed with hypertension compared to Caucasians, APOR = 0.73, 99% CI, 0.68–0.79, P < 0.001 .
Conclusions
There was racial/ethnic variability in hypertension prevalence in this large sample of non-institutionalized US residents, with the highest prevalence of hypertension observed among African Americans. These disparities were not removed after controlling for relevant covariates including co-morbidities.
Zitieren
APA
Opara, F., Hawkins, K., Sundaram, A., Merchant, M., Rasmussen, S., & Holmes, L. (2013). Impact of Comorbidities on Racial/Ethnic Disparities in Hypertension in the United States. ISRN Public Health. https://doi.org/10.1155/2013/967518
Vancouver
Opara F, Hawkins K, Sundaram A, Merchant M, Rasmussen S, Holmes L. Impact of Comorbidities on Racial/Ethnic Disparities in Hypertension in the United States. ISRN Public Health. 2013. doi:10.1155/2013/967518
BibTeX
@article{Opara2013,
author = {Opara, Franklin and Hawkins, Kimberly and Sundaram, Aparna and Merchant, Munira and Rasmussen, Sandra and Holmes, Laurens},
title = {Impact of Comorbidities on Racial/Ethnic Disparities in Hypertension in the United States},
journal = {ISRN Public Health},
year = {2013},
doi = {10.1155/2013/967518}
}
EUVIMED